Not Yet Recruiting
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China